Grants and Contributions:
Title:
Peak Detection and Speech Annotation Development
Agreement Number:
958729
Agreement Value:
$50,000.00
Agreement Date:
Nov 1, 2020 - May 14, 2021
Description:
The PainTrace® medical device is a monitoring system that provides a quantitative measure of pain in humans and in animals. Data analysis of pain peak level measurements and including the annotation of activity, examination, treatments, drug administration, and anatomy is paramount to the expansion of the application of the PainTrace® as a necessary health monitoring tool. To that end, peak detection algorithms to identify features and trends as changes in levels of pain as measured by the PainTrace® medical device and reliable speech to text annotation must be developed. Using analytics PainTrace® will have the capacity to provide a completely objective pain scale.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Charlottetown, Prince Edward Island, CA C1A 4K9
Reference Number:
172-2020-2021-Q3-958729
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
775766280
Recipient Type:
For-profit organization
Recipient's Legal Name:
BioTraceIT Ltd.
Federal Riding Name:
Charlottetown
Federal Riding Number:
11002
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710